We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Pelvic Floor Muscle Stimulator Treats Urinary Incontinence

By HospiMedica International staff writers
Posted on 29 Nov 2018
Print article
Image: Research shows that muscle stimulation can reduce incontinence (Photo courtesy of Atlantic Therapeutics).
Image: Research shows that muscle stimulation can reduce incontinence (Photo courtesy of Atlantic Therapeutics).
An externally worn stimulation device treats the root cause of stress urinary incontinence (SUI), rather than just managing the symptoms.

The Atlantic Therapeutics (Galway, Ireland) Innovo system is a non-invasive transcutaneous muscle exerciser, resembling a pair of cycling shorts, which uses electrical stimulation to deliver 180 precise, complete contractions to the pelvic floor muscles. During each 30-minute exercise session, the system strengthens and re-educates the network of muscles that control bladder function. A hand-held controller connected to the shorts allows users to increase the intensity of the stimulations, and a smartphone app is also available.

Innovo may be prescribed as a front-line therapy to those suffering SUI, or as a second line therapy to those that have previously failed physical therapy (in the form of supervised or unsupervised pelvic floor exercises, also known as Kegel exercises). A pivotal randomized controlled trial held in the United States demonstrated the efficacy and safety of the device, with 87.2% of patients treated dry or mild after a 12-week treatment period, and 93% experiencing improvement in just four weeks. An earlier sham-controlled trial in Europe also demonstrated significant improvement across all study endpoints.

“For the first time, physicians in the United States can offer their patients a safe, clinically effective, noninvasive home-based treatment,” said Steve Atkinson, CEO of Atlantic Therapeutics. “Innovo therapy is a compelling treatment option for all those women who today simply suffer in silence from stress urinary incontinence.”

“Innovo offers a new frontline therapeutic option for the millions of American women living with stress urinary incontinence, and in a significant group could delay or prevent the need for higher risk surgery or medical intervention,” said Elizabeth LaGro, vice president of The Simon Foundation for Continence (Wilmette, IL, USA).

SUI is the loss of bladder control or involuntary loss of urine when coughing, laughing, sneezing, or during heavy lifting, or simply getting up from a chair. SUI is the most common type of incontinence suffered by women, especially older women and women who have given birth. SUI also affects men, especially following prostate surgery. Other causes include weak pelvic muscles or a weak sphincter muscle; chronic coughing, smoking and obesity may also lead to SUI.

Related Links:
Atlantic Therapeutics

Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Orthopedic Navigation System
OrthoPilot Elite
New
EBUS-TBNA Endoscope
BF-UC190F

Print article

Channels

Critical Care

view channel
Image: The study revealed how stress-related alterations in blood flow and blood vessel function are closely associated with heart disease (Photo courtesy of 123RF)

New Cardiovascular Risk Score Uses Stress Test to Predict Heart Disease More Accurately

A recent study has paved the way for the development of a new cardiovascular reactivity risk score, which could improve the ability to identify high-risk patients under stress and accelerate their diagnosis... Read more

Surgical Techniques

view channel
Image: Application of Pericelle to the porcine model of femoral arterio-venous fistula (Photo courtesy of Bioactive Materials, DOI:10.1016/j.bioactmat.2024.10.005)

Nanotechnology-Based Drug Delivery System Could Help Dialysis and Heart Patients Avoid Repeat Surgeries

Revascularization procedures are essential for treating cardiovascular disease by restoring the necessary blood flow. For instance, a surgeon may transfer a vein from the leg to the heart to help patients... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.